Published in Neurology on April 01, 1998
Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab (2011) 1.58
Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care (2007) 1.42
When you look for evidence and find too much: systematic reviews to the rescue. Neurology (1998) 1.41
Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry (2000) 1.26
Vascular plasticity in cerebrovascular disorders. J Cereb Blood Flow Metab (2011) 1.15
Spreading depolarization: a possible new culprit in the delayed cerebral ischemia of subarachnoid hemorrhage. Arch Neurol (2010) 1.03
Reprogramming the host response in bacterial meningitis: how best to improve outcome? Clin Microbiol Rev (2003) 0.95
Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. Biomed Res Int (2014) 0.90
Treatment options for cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurotherapeutics (2012) 0.89
Cerebral Vasospasm in Subarachnoid Hemorrhage. Curr Treat Options Neurol (2005) 0.89
Medical Management of Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage: A Review of Current and Emerging Therapeutic Interventions. Neurol Res Int (2013) 0.89
Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature. Interv Neurol (2013) 0.88
Ischaemia triggered by spreading neuronal activation is inhibited by vasodilators in rats. J Physiol (2001) 0.86
Current controversies in the prediction, diagnosis, and management of cerebral vasospasm: where do we stand? Neurol Res Int (2013) 0.82
Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage. Ann Intensive Care (2011) 0.81
Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab (2010) 0.79
Calcium and potassium channels in experimental subarachnoid hemorrhage and transient global ischemia. Stroke Res Treat (2012) 0.78
Effect of endothelin receptor antagonists on clinically relevant outcomes after experimental subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab (2015) 0.78
Cerebral microcirculatory failure after subarachnoid hemorrhage is reversed by hyaluronidase. J Cereb Blood Flow Metab (2015) 0.78
Delayed cerebral ischaemia prevention and treatment after aneurysmal subarachnoid haemorrhage: a systematic review. Br J Anaesth (2016) 0.77
Treatment of ruptured intracranial aneurysms: report from a low-volume center. Wien Klin Wochenschr (2006) 0.77
Effect of magnesium sulfate therapy on patients with aneurysmal subarachnoid hemorrhage using serum S100B protein as a prognostic marker. Neurosurg Rev (2011) 0.76
Hot spots and future directions of research on the neuroprotective effects of nimodipine. Neural Regen Res (2014) 0.75
Cerebral vasospasm in intracerebral hemorrhage-case report. J Vasc Interv Neurol (2009) 0.75
Advances in the understanding of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. F1000Res (2015) 0.75
Gene expression in a canine basilar artery vasospasm model: a genome-wide network-based analysis. Neurosurg Rev (2008) 0.75
Posterior reversible encephalopathy syndrome postautologous peripheral stem cell transplantation for multiple myeloma. BMJ Case Rep (2012) 0.75
Persistent autoregulatory disturbance after angioplasty for cerebral vasospasm. A case report. Interv Neuroradiol (2004) 0.75
Vasospasm Risk in Surgical ICU Patients With Grade I Subarachnoid Hemorrhage. Neurohospitalist (2016) 0.75
Interobserver agreement for the assessment of handicap in stroke patients. Stroke (1988) 20.14
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2001) 5.18
Subarachnoid haemorrhage: diagnosis, causes and management. Brain (2001) 4.60
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke (1997) 4.13
Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke (1998) 4.12
Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke (2001) 3.90
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke (1996) 3.67
Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46
[Fever, large eyes and confusion; the anticholinergic syndrome]. Ned Tijdschr Geneeskd (2002) 3.30
Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry (2007) 3.17
High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology (1990) 3.05
[Those who cannot remember the past are condemned to repeat it]. Ned Tijdschr Geneeskd (2006) 2.98
Intracerebral hematomas during anticoagulant treatment. Stroke (1990) 2.97
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke (2005) 2.69
Injection with methylprednisolone proximal to the carpal tunnel: randomised double blind trial. BMJ (1999) 2.57
[The Cochrane Collaboration; systematic reviews of knowledge from randomized studies]. Ned Tijdschr Geneeskd (1995) 2.56
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke (1999) 2.49
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ (2001) 2.43
Spinal dural arteriovenous fistulas: a congestive myelopathy that initially mimics a peripheral nerve disorder. Brain (2006) 2.35
Association of intraoperative transcranial doppler monitoring variables with stroke from carotid endarterectomy. Stroke (2000) 2.33
Hypertension and cerebral white matter lesions in a prospective cohort study. Brain (2002) 2.31
Circle of Willis: morphologic variation on three-dimensional time-of-flight MR angiograms. Radiology (1998) 2.30
Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet (1991) 2.30
The diagnosis of subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1990) 2.29
Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet (2001) 2.29
Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology (1985) 2.18
Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry (1990) 2.15
Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke (1994) 2.14
Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation (1995) 2.13
Carotid endarterectomy with transcranial Doppler and electroencephalographic monitoring. A prospective study in 130 operations. Stroke (1993) 2.13
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08
The time course of aneurysmal haemorrhage on computed tomograms. Neuroradiology (1982) 2.06
Ticlopidine, trials, and torture. Stroke (1994) 2.04
Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone? J Neurol Neurosurg Psychiatry (1999) 2.03
[There is no such thing as the CVA]. Ned Tijdschr Geneeskd (1991) 2.03
[Functional imaging of the brain in the investigation of chronic unexplained pain]. Ned Tijdschr Geneeskd (2007) 2.02
[Measuring the functional status of patients in clinical trials using modern clinimetric methods]. Ned Tijdschr Geneeskd (2002) 2.01
Xanthochromia after subarachnoid haemorrhage needs no revisitation. J Neurol Neurosurg Psychiatry (1989) 1.95
Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline. J Neurol Neurosurg Psychiatry (2001) 1.92
Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors. Stroke (1997) 1.92
The clinical course of perimesencephalic nonaneurysmal subarachnoid hemorrhage. Ann Neurol (1991) 1.89
Warning headache in aneurysmal subarachnoid hemorrhage. A case-control study. Arch Neurol (1988) 1.89
Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg (1985) 1.87
Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry (1996) 1.87
Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain (2005) 1.85
Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke (1990) 1.83
Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke (1998) 1.82
Recurrent ischemia in symptomatic carotid occlusion: prognostic value of hemodynamic factors. Neurology (2000) 1.80
Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke. BMJ (1988) 1.76
Long-term follow-up of 71 patients with thunderclap headache mimicking subarachnoid haemorrhage. Lancet (1988) 1.73
Changes in functional outcome and quality of life in patients and caregivers after aneurysmal subarachnoid hemorrhage. J Neurosurg (2001) 1.73
[On the way to our 200th anniversary]. Ned Tijdschr Geneeskd (2007) 1.72
Spinal infarction. A follow-up study. Stroke (1993) 1.72
Apnoea testing to confirm brain death in clinical practice. J Neurol Neurosurg Psychiatry (1986) 1.72
Perimesencephalic hemorrhage. Exclusion of vertebrobasilar aneurysms with CT angiography. Stroke (1999) 1.69
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69
[Diagnostic image (156). A man with a hematoma behind the ear. Mastoid bone fracture]. Ned Tijdschr Geneeskd (2003) 1.69
Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation (1999) 1.69
[Creative mathematics with clopidogrel; exaggeration of the preventive effect by manufacturer]. Ned Tijdschr Geneeskd (1999) 1.68
Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group. Lancet (1992) 1.68
First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: influence of diagnostic bias. Schizophr Res (2010) 1.68
Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry (1993) 1.67
A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol (1999) 1.67
Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy. J Neurol Sci (1985) 1.67
Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Neurology (2007) 1.64
Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage. BMJ (1995) 1.62